G. Croteau

发表

HLA-DR polymorphism affects the interaction with CD4

Eric O Long, R. Sékaly, N. Labrecque, 1995, The Journal of experimental medicine.

2',6'-Dimethylphenoxyacetyl: a new achiral high affinity P(3)-P(2) ligand for peptidomimetic-based HIV protease inhibitors.

L. Tong, S. Pav, D. Lamarre, 2000, Journal of medicinal chemistry.

The CD4 molecule is not always required for the T cell response to bacterial enterotoxins

R. Geha, R. Sékaly, G. Croteau, 1991, The Journal of experimental medicine.

Antiviral properties of palinavir, a potent inhibitor of the human immunodeficiency virus type 1 protease

D. Lamarre, C. Yoakim, P. Anderson, 1997, Antimicrobial agents and chemotherapy.

Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors

D. Lamarre, L. Doyon, L. Pilote, 1996, Journal of virology.

HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells

P. Marrack, R. Sékaly, J. Kappler, 1990, The Journal of experimental medicine.

Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors

D. Lamarre, L. Doyon, G. McKercher, 1997, Journal of virology.

CD4 and CD8 recognition of class II and class I molecules of the major histocompatibility complex.

R. Sékaly, S. Fleury, G. Croteau, 1991, Seminars in immunology.

Phase transition of [(C6H5)3PCH3]+(TCNQ)-2 and electrical transport properties

A. Lakhani, G. Croteau, N. K. Hota, 1981 .

Potent HIV protease inhibitors containing a novel (hydroxyethyl)amide isostere.

L. Tong, S. Pav, D. Lamarre, 1997, Journal of medicinal chemistry.

Separation of M-protein from influenza virus by agarose gel electrophoresis.

G. Croteau, J. Lecomte, 1981, Journal of virological methods.

Mutations in human CD4 impair the functional interaction with different human and mouse class II isotypes and alleles.

Eric O Long, R. Sékaly, S. Fleury, 1996, Journal of immunology.